Clinical Trial Update: TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fasiglifam (TAK-875) in combination with sitagliptin for adults with Type 2 diabetes mellitus was terminated, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• TAK-875 (fasiglifam)

Snippet

Sponsor: Takeda | Conditions: Diabetes | Phase 3 | Status: TERMINATED | Results posted: 2016-06-01